DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS
or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising thes...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; pol |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PABBISETTY KUMAR B SMITH II LEON M WANG YUFENG FANG TIANAN PINTO DONALD J.P. PINTO DILGER ANDREW K EWING WILLIAM R YANG WU CORTE JAMES R GILLIGAN PAUL J |
| description | or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2880026TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2880026TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2880026TT33</originalsourceid><addsrcrecordid>eNrjZNB28fSIdAnyD4gM8nTx93NVCDBUcAxWcHN0DvEPUojwdFTw9PPwdPIE8oJ5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8gI-RhYWBgZFZSIixMTFqAH4oJV4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS</title><source>esp@cenet</source><creator>PABBISETTY KUMAR B ; SMITH II LEON M ; WANG YUFENG ; FANG TIANAN ; PINTO DONALD J.P. PINTO ; DILGER ANDREW K ; EWING WILLIAM R ; YANG WU ; CORTE JAMES R ; GILLIGAN PAUL J</creator><creatorcontrib>PABBISETTY KUMAR B ; SMITH II LEON M ; WANG YUFENG ; FANG TIANAN ; PINTO DONALD J.P. PINTO ; DILGER ANDREW K ; EWING WILLIAM R ; YANG WU ; CORTE JAMES R ; GILLIGAN PAUL J</creatorcontrib><description>or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170831&DB=EPODOC&CC=PL&NR=2880026T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170831&DB=EPODOC&CC=PL&NR=2880026T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PABBISETTY KUMAR B</creatorcontrib><creatorcontrib>SMITH II LEON M</creatorcontrib><creatorcontrib>WANG YUFENG</creatorcontrib><creatorcontrib>FANG TIANAN</creatorcontrib><creatorcontrib>PINTO DONALD J.P. PINTO</creatorcontrib><creatorcontrib>DILGER ANDREW K</creatorcontrib><creatorcontrib>EWING WILLIAM R</creatorcontrib><creatorcontrib>YANG WU</creatorcontrib><creatorcontrib>CORTE JAMES R</creatorcontrib><creatorcontrib>GILLIGAN PAUL J</creatorcontrib><title>DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS</title><description>or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB28fSIdAnyD4gM8nTx93NVCDBUcAxWcHN0DvEPUojwdFTw9PPwdPIE8oJ5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8gI-RhYWBgZFZSIixMTFqAH4oJV4</recordid><startdate>20170831</startdate><enddate>20170831</enddate><creator>PABBISETTY KUMAR B</creator><creator>SMITH II LEON M</creator><creator>WANG YUFENG</creator><creator>FANG TIANAN</creator><creator>PINTO DONALD J.P. PINTO</creator><creator>DILGER ANDREW K</creator><creator>EWING WILLIAM R</creator><creator>YANG WU</creator><creator>CORTE JAMES R</creator><creator>GILLIGAN PAUL J</creator><scope>EVB</scope></search><sort><creationdate>20170831</creationdate><title>DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS</title><author>PABBISETTY KUMAR B ; SMITH II LEON M ; WANG YUFENG ; FANG TIANAN ; PINTO DONALD J.P. PINTO ; DILGER ANDREW K ; EWING WILLIAM R ; YANG WU ; CORTE JAMES R ; GILLIGAN PAUL J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2880026TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PABBISETTY KUMAR B</creatorcontrib><creatorcontrib>SMITH II LEON M</creatorcontrib><creatorcontrib>WANG YUFENG</creatorcontrib><creatorcontrib>FANG TIANAN</creatorcontrib><creatorcontrib>PINTO DONALD J.P. PINTO</creatorcontrib><creatorcontrib>DILGER ANDREW K</creatorcontrib><creatorcontrib>EWING WILLIAM R</creatorcontrib><creatorcontrib>YANG WU</creatorcontrib><creatorcontrib>CORTE JAMES R</creatorcontrib><creatorcontrib>GILLIGAN PAUL J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PABBISETTY KUMAR B</au><au>SMITH II LEON M</au><au>WANG YUFENG</au><au>FANG TIANAN</au><au>PINTO DONALD J.P. PINTO</au><au>DILGER ANDREW K</au><au>EWING WILLIAM R</au><au>YANG WU</au><au>CORTE JAMES R</au><au>GILLIGAN PAUL J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS</title><date>2017-08-31</date><risdate>2017</risdate><abstract>or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; pol |
| recordid | cdi_epo_espacenet_PL2880026TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A32%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PABBISETTY%20KUMAR%20B&rft.date=2017-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2880026TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |